The Association of Lipids, Lipoproteins and Apolipoproteins Patterns with Cardiovascular Disease in Patients with Type 2 Diabetes

References (41)

1. 1 Global estimates of the prevalence of diabetes for 2010 and 2030 [DOI]
2. 2 The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives [DOI]
3. 3 A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia [DOI]
4. 4 Reactive oxygen species in cardiovascular disease [DOI]
5. 5 Lipids and Lipoproteins in Patients With Type 2 Diabetes [DOI]
6. 6 Vascular complications in diabetes mellitus: the role of endothelial dysfunction [DOI]
7. 7 Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications [DOI]
8. 8 Diabetic Dyslipidemia: Causes and Consequences [DOI]
9. 9 Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel [DOI]
10. 10 Oxidative stress and diabetes mellitus [DOI]
11. 11 Oxidative Stress [DOI]
12. 12 Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes [DOI]
13. 13 Metabolism, hypoxia and the diabetic heart [DOI]
14. 14 Is Glucose Control Important for Prevention of Cardiovascular Disease in Diabetes? [DOI]
15. 15 Atherothrombosis, inflammation, and diabetes [DOI]
16. 16 Glycation and oxidation: A role in the pathogenesis of atherosclerosis [DOI]
17. 17 Lipoprotein(a), Measured With an Assay Independent of Apolipoprotein(a) Isoform Size, and Risk of Future Cardiovascular Events Among Initially Healthy Women [DOI]
18. 18 Reactive oxygen species, reactive nitrogen species and antioxidants in etiopathogenesis of diabetes mellitus type-2 [DOI]
19. 19 LDL-C/HDL-C Ratio Predicts Carotid Intima-Media Thickness Progression Better Than HDL-C or LDL-C Alone [DOI]
20. 20 Lipoprotein(a) in Cardiovascular Diseases [DOI]
21. 21 Comorbidity Burden and Health Services Use in Community-Living Older Adults with Diabetes Mellitus: A Retrospective Cohort Study [DOI]
22. 22 Dyslipidemia in type 2 diabetes mellitus [DOI]
23. 23 Pathogenesis and pathophysiology of accelerated atherosclerosis in the diabetic heart [DOI]
24. 24 Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications [DOI]
25. 25 Risk of Macrovascular Complications in Type 2 Diabetes Mellitus: Endothelial Microparticle Profiles [DOI]
26. 26 Observational study to evaluate the safety and efficacy of saroglitazar in Indian diabetic dyslipidemia patients [DOI]
27. 27 The relationship between lipoprotein(a) and the complications of diabetes mellitus [DOI]
28. 28 Therapies for diabetic dyslipidaemia [DOI]
29. 29 Lipoprotein (a) in type 2 diabetes mellitus: Relation to LDL:HDL ratio and glycemic control [DOI]
30. 30 An overview on management of diabetic dyslipidemia [DOI]
31. 31 A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia [DOI]
32. 32 The Lipid Profile and Mortality Risk in Elderly Type 2 Diabetic Patients: A Ten-Year Follow-Up Study (ZODIAC-13) [DOI]
33. 33 Lipoprotein(a) is not related to markers of insulin resistance in pregnancy [DOI]
34. 34 Incidence and predictors for cardiovascular disease in Chinese patients with type 2 diabetes mellitus – a population-based retrospective cohort study [DOI]
35. 35 Peripheral atherosclerosis and serum lipoprotein(a) in diabetes. [DOI]
36. 36 Changes in oxidant‐antioxidant status in young diabetic patients from clinical onset onwards [DOI]
37. 37 Lipoprotein (a), C-reactive protein and some metabolic cardiovascular risk factors in type 2 DM [DOI]
38. 38 Lipoprotein ( a ) and Atherogenic Indices in Sudanese Patients with Type 2 Diabetes [DOI]
39. 39 Análisis del proceso asistencial de los pacientes con diabetes mellitus tipo 2 y comorbilidad asociada atendidos en el Sistema Nacional de Salud en España: una perspectiva de los profesionales médicos. Estudio IMAGINE [DOI]
40. 40 Elusive proatherothrombotic role of Lp(a): a new direction? [DOI]
41. 41 Review: The pathogenesis of type 2 diabetes and cardiovascular disease [DOI]

Cited by 0

No indexed citations yet.

Related research

• Thyroid Dysfunction and Insulin Resistance — shares topic coverage
• Vitamin D and Insulin Resistance in Metabolic Syndrome — shares topic coverage
• The Intersection of Hepcidin and Polycystic Ovary Syndrome: A Review of Current Understanding — shares topic coverage
• Neck Circumference as a Possible Indicator of Cardiometabolic Risk among Nigerian Adults with Type 2 Diabetes — shares topic coverage
• Sleep Duration, Quality, and Timing as Modifiable Determinants of Growth and Endocrine Health in Children and Adolescents: A Critical Narrative Review — shares topic coverage